abstract
An appealing strategy that overcomes the hydrophobicity of pristine graphene and favors its interaction with biological media is colloidal stabilization in aqueous medium with the support of a biomolecule, such as flavin mononucleotide (FMN), as exfoliating/dispersing agent. However, to establish FMN-stabilized graphene (PG-FMN) as suitable for use in biomedicine, its biocompatibility must be proved by a complete assessment of cytotoxicity at the cellular level. Furthermore, if PG-FMN is to be proposed as a theranostic agent, such a study should include both healthy and tumoral cells and its outcome should reveal the nanomaterial as selectively toxic to the latter. Here, we provide an in-depth comparative in vitro analysis of the response of Saos-2 human sarcoma osteoblasts (model tumor cells) and MC3T3-E1 murine preosteoblasts (undifferentiated healthy cells) upon incubation with different concentrations (10-50 mu g mL(-1)) of PG-FMN dispersions constituted by flakes with different average lateral size (90 and 270 nm). Specifically, the impact of PG-FMN on the viability and cell proliferation, reactive oxygen species (ROS) production, and the cellular incorporation process, cell-cycle progression, and apoptosis has been evaluated. PG-FMN was found to be toxic to both types of cells by increasing ROS production and triggering cell-cycle arrest. The present results constitute a cautionary tale on the need to establish the effect of a nanomaterial not only on tumor cells but also on healthy ones before proposing it as anticancer agent.
keywords
NANOMATERIALS; APOPTOSIS; OXIDE; THERAPEUTICS; GENERATION; PRISTINE; HYBRIDS; STRESS; FLAKES
subject category
Nanoscience & Nanotechnology; Materials Science, Biomaterials
authors
Cicuendez, M; Coimbra, A; Santos, J; Oliveira, H; Ayan-Varela, M; Paredes, UI; Villar-Rodil, S; Vila, M; Silva, VS
our authors
Groups
acknowledgements
The characterization of the graphene dispersions by DLS was performed at the ICTS NANBIOSIS by the Nanostructured Liquids Unit (U12) of the CIBER in Bioengineering, Biomaterials & Nanomedicine (CIBER-BBN), located at the IQAC-CSIC. J. I. P. and S. V.-R. gratefully acknowledge funding by the Spanish Ministerio de Ciencia, Innovacion y Universidades (MICINN), Agencia Estatal de Investigacion (AEI), and the European Regional Development Fund (ERDF) through project RTI2018-100832-B-I00, as well as Plan de Ciencia, Tecnologia e Innovacion (PCTI) 2013-2017 del Principado de Asturias and the ERDF (project IDI/2018/000233). M.C. acknowledges the financial support from the FCT [SFRH/BPD/101468/2014 Postdoctoral Grant]. V.S.S. was funded by national funds (OE), through FCT, in the scope of the framework contract foreseen in the numbers 4, 5, and 6 of article 23, of the Decree-Law 57/2016, of August 29, changed by Law 57/2017, of July 19. FCT, Fundac commaa~o para a Cie<^>ncia e a Tecnologia, I.P., is also acknowledged for the research contract under Scientific Employment Stimulus to H.O. (CEECIND/04050/2017). Thanks are due to CESAM (UIDB/50017/2020+UIDP/50017/2020) for the financial support.